# Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults

> **NCT06919926** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 60 (estimated)

## Conditions studied

- Hippocampal Overactivity
- Dementia

## Interventions

- **DRUG:** AGB101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06919926
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-17
- **Primary completion:** 2027-05
- **Final completion:** 2028-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919926, "Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06919926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*